In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs

被引:26
|
作者
Wongsrichanalai, C
Lin, K
Pang, LW
Faiz, MA
Noedl, H
Wimonwattrawatee, T
Laoboonchai, A
Kawamoto, F
机构
[1] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand
[2] Minist Hlth, Dept Hlth, Vector Borne Dis Control Project, Yangon, Myanmar
[3] Chittagong Med Coll, Dept Med, Chittagong, Bangladesh
[4] Univ Vienna, Inst Pathophysiol, Dept Specif Prophylaxis & Trop Med, Vienna, Austria
[5] Nagoya Univ, Sch Med, Dept Int Hlth, Nagoya, Aichi 466, Japan
来源
关键词
D O I
10.4269/ajtmh.2001.65.450
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In vitro drug susceptibility profiles were assessed in 75 Plasmodium falciparum isolates from 4 sites in Myanmar. Except at Mawlamyine, the site closest to the Thai border, prevalence and degree of resistance to mefloquine were lower among the Myanmar isolates as compared with those from Thailand. Geometric mean concentration that inhibits 50% (IC50) and 90% (IC90) of Mawlamyine isolates were 51 nM (95% confidence interval [CI], 40-65) and 124 nM (95% Cl, 104-149), respectively. At the nearest Thai site, Maesod, known for high-level multidrug resistance, the corresponding values for mefloquine IC50 and IC90 were 92 nM (95% Cl, 71-121) and 172 nM (95% CI, 140-211). Mefloquine susceptibility of P. falciparum in Myanmar, except for Mawlamyine, was consistent with clinical-parasitological efficacy in semi-immune people. High sensitivity to artemisinin compounds was observed in this geographical region. The data suggest that highly mefloquine-resistant P. falciparum is concentrated in a part of the Thai-Myanmar border region.
引用
收藏
页码:450 / 455
页数:6
相关论文
共 50 条
  • [21] The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs
    Quashie, N. B.
    Duah, N. O.
    Abuaku, B.
    Koram, K. A.
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2007, 101 (05): : 391 - 398
  • [22] In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda
    Nsobya, Samuel L.
    Kiggundu, Moses
    Nanyunja, Sarah
    Joloba, Moses
    Greenhouse, Bryan
    Rosenthal, Philip J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 1200 - 1206
  • [23] In Vitro Susceptibility of Plasmodium falciparum Isolates from the China-Myanmar Border Area to Piperaquine and Association with Candidate Markers
    Si, Yu
    Zeng, Weilin
    Li, Na
    Wang, Chengqi
    Siddiqui, Faiza
    Zhang, Jie
    Pi, Liang
    He, Xi
    Zhao, Luyi
    Wang, Siqi
    Zhao, Hui
    Li, Xinxin
    Yang, Qi
    Miao, Jun
    Yang, Zhaoqing
    Cui, Liwang
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [24] In vitro antimalarial susceptibility profile and PRCRT/PFMDR-1 genotypes of Plasmodium falciparum field isolates from Malawi
    Nkhoma, Standwell
    Molyneux, Malcolm
    Ward, Stephen
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (06): : 1107 - 1112
  • [25] In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos)
    Mayxay, Mayfong
    Barends, Marion
    Brockman, Alan
    Jaidee, Anchalee
    Nair, Shalini
    Sudimack, Dan
    Pongvongsa, Tiengkham
    Phompida, Samlane
    Phetsouvanh, Rattanaxay
    Anderson, Tim
    White, Nicholas J.
    Newton, Paul N.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (02): : 245 - 250
  • [26] In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs
    Pradines, B
    Rogier, C
    Fusai, T
    Tall, A
    Trape, JF
    Doury, JC
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (03): : 354 - 357
  • [27] Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda
    Fukuda, Naoyuki
    Tachibana, Shin-Ichiro
    Ikeda, Mie
    Sakurai-Yatsushiro, Miki
    Balikagala, Betty
    Katuro, Osbert T.
    Yamauchi, Masato
    Emoto, Sakurako
    Hashimoto, Muneaki
    Yatsushiro, Shouki
    Sekihara, Makoto
    Mori, Toshiyuki
    Hirai, Makoto
    Opio, Walter
    Obwoya, Paul S.
    Auma, Mary A.
    Anywar, Denis A.
    Kataoka, Masatoshi
    Palacpac, Nirianne M. Q.
    Odongo-Aginya, Emmanuel, I
    Kimura, Eisaku
    Ogwang, Martin
    Horii, Toshihiro
    Mita, Toshihiro
    PARASITOLOGY INTERNATIONAL, 2021, 81
  • [28] In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon
    Atteke, C
    Ndong, JMM
    Aubouy, A
    Maciejewski, L
    Brocard, J
    Lébibi, J
    Deloron, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 1021 - 1024
  • [29] In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs
    Ang, HH
    Lam, CK
    Wah, MJ
    CHEMOTHERAPY, 1996, 42 (05) : 318 - 323
  • [30] In vitro susceptibility of Plasmodium falciparum isolates from gabon to chloroquine and cycloguanil.
    Pradines, B
    Mamfoumbi, MM
    Keundjian, A
    Lebeau, C
    Fusai, T
    Medang, MO
    Rogier, C
    Parzy, D
    Kombila, M
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1999, 92 (02): : 91 - 94